73 related articles for article (PubMed ID: 18997475)
1. The impact of the DNA-repair gene MGMT in malignant gliomas.
Hutterer M
Neuroepidemiology; 2009; 32(1):30-1. PubMed ID: 18997475
[No Abstract] [Full Text] [Related]
2. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
[TBL] [Abstract][Full Text] [Related]
3. [The clinical research of the MGMT expression levels in glioma pations].
Xia HC; Zhu ZQ; Liu L; Tian HL; Sun Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):265-7. PubMed ID: 22097602
[TBL] [Abstract][Full Text] [Related]
4. [Strategy for studying gene methylation: the example of MGMT].
Fina F; Nanni-Metellus I; Courdy C; Figarella-Branger D; Martin PM; Ouafik L
Ann Pathol; 2009 Nov; 29 Spec No 1():S37-9. PubMed ID: 19887248
[No Abstract] [Full Text] [Related]
5. Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase.
Lavon I; Fuchs D; Zrihan D; Efroni G; Zelikovitch B; Fellig Y; Siegal T
Cancer Res; 2007 Sep; 67(18):8952-9. PubMed ID: 17875738
[TBL] [Abstract][Full Text] [Related]
6. O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation is significantly less frequent in ependymal tumours as compared to malignant astrocytic gliomas.
Koos B; Peetz-Dienhart S; Riesmeier B; Frühwald MC; Hasselblatt M
Neuropathol Appl Neurobiol; 2010 Jun; 36(4):356-8. PubMed ID: 20202118
[No Abstract] [Full Text] [Related]
7. MGMT as a potential stratification marker in relapsed high-grade glioma of children: the HIT-GBM experience.
Schlosser S; Wagner S; Mühlisch J; Hasselblatt M; Gerss J; Wolff JE; Frühwald MC
Pediatr Blood Cancer; 2010 Feb; 54(2):228-37. PubMed ID: 19856394
[TBL] [Abstract][Full Text] [Related]
8. The L84F polymorphism in the O6-Methylguanine-DNA-Methyltransferase (MGMT) gene is associated with increased hypoxanthine phosphoribosyltransferase (HPRT) mutant frequency in lymphocytes of tobacco smokers.
Hill CE; Wickliffe JK; Guerin AT; Kinslow CJ; Wolfe KJ; Ammenheuser MM; Abdel-Rahman SZ
Pharmacogenet Genomics; 2007 Sep; 17(9):743-53. PubMed ID: 17700363
[TBL] [Abstract][Full Text] [Related]
9. [The genome atlas of brain tumors].
Natsume A; Motomura K; Wakabayashi T
Nihon Rinsho; 2010 Aug; 68 Suppl 8():473-80. PubMed ID: 20979298
[No Abstract] [Full Text] [Related]
10. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.
Chamberlain MC
Neurology; 2014 Jun; 82(23):2147-8. PubMed ID: 24912510
[No Abstract] [Full Text] [Related]
11. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
[TBL] [Abstract][Full Text] [Related]
12. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.
Kaina B; Christmann M; Naumann S; Roos WP
DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for low-grade gliomas: emerging consensus on its benefits.
Wen PY; DeAngelis LM
Neurology; 2007 May; 68(21):1762-3. PubMed ID: 17515537
[No Abstract] [Full Text] [Related]
14. Single-copy gain of chromosome 1q is a negative prognostic marker in pediatric nonependymal, nonpilocytic gliomas.
Miwa T; Hirose Y; Sasaki H; Ezaki T; Yoshida K; Kawase T
Neurosurgery; 2011 Jan; 68(1):206-12. PubMed ID: 21099717
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional expression of glioma chemotherapy drugs associated marker molecules in gliomas and normal brain tissues.
Zhao Y; Xue Y; Zhang Q; Wang K; Yin J; Lou M
Cancer Biomark; 2013; 13(1):59-66. PubMed ID: 23736022
[TBL] [Abstract][Full Text] [Related]
16. [Application of double created restriction site PCR-RFLP to identify MGMT gene polymorphisms].
Wang W; Miao W; Qiu Y; Xia Z
Wei Sheng Yan Jiu; 2008 Jan; 37(1):4-7. PubMed ID: 18421851
[TBL] [Abstract][Full Text] [Related]
17. MGMT gene is aberrantly methylated from the early stages of colorectal cancers.
Hibi K; Goto T; Mizukami H; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Hepatogastroenterology; 2009; 56(96):1642-4. PubMed ID: 20214209
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53.
Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H
DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750
[TBL] [Abstract][Full Text] [Related]
19. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
[TBL] [Abstract][Full Text] [Related]
20. Favoritism in DNA methylation.
Hitchins MP; Ward RL
Cancer Prev Res (Phila); 2009 Oct; 2(10):847-9. PubMed ID: 19789293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
